Geodon
ziprasidone mesylate
- Strength
- 20 mg/mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Atypical Antipsychotic
Viatris Specialty LLC
Geodon
ziprasidone
Listed by ROERIG
- Strength
- 20 mg/1
- Form
- Capsule
- Route
- Oral
- Class
- Atypical Antipsychotic
What it contains
- Ziprasidone 20 mg/1
FDA record
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Atypical Antipsychotic |
| Approval route | NDA — original brand approval |
| NDC code | 0049-0352 |
| FDA application | NDA020825 |
| Package sizes listed | 1 |
| Marketed since | November 2021 |
Other products containing Ziprasidone
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Geodon
ziprasidone
- Strength
- 20 mg/1
- Form
- Capsule
- Class
- Atypical Antipsychotic
Viatris Specialty LLC
Geodon
ziprasidone
- Strength
- 60 mg/1
- Form
- Capsule
- Class
- Atypical Antipsychotic
Viatris Specialty LLC
Geodon
ziprasidone
- Strength
- 60 mg/1
- Form
- Capsule
- Class
- Atypical Antipsychotic
ROERIG
Geodon
ziprasidone mesylate
- Strength
- 20 mg/mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Atypical Antipsychotic
ROERIG
Geodon
ziprasidone
- Strength
- 80 mg/1
- Form
- Capsule
- Class
- Atypical Antipsychotic
Viatris Specialty LLC
Geodon
ziprasidone
- Strength
- 80 mg/1
- Form
- Capsule
- Class
- Atypical Antipsychotic
ROERIG
Geodon
ziprasidone
- Strength
- 40 mg/1
- Form
- Capsule
- Class
- Atypical Antipsychotic
ROERIG
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.